CN110291189A - 单细胞人多潜能干细胞的传代和收获制剂 - Google Patents
单细胞人多潜能干细胞的传代和收获制剂 Download PDFInfo
- Publication number
- CN110291189A CN110291189A CN201880007148.4A CN201880007148A CN110291189A CN 110291189 A CN110291189 A CN 110291189A CN 201880007148 A CN201880007148 A CN 201880007148A CN 110291189 A CN110291189 A CN 110291189A
- Authority
- CN
- China
- Prior art keywords
- cell
- preparation
- cells
- stem cell
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003306 harvesting Methods 0.000 title claims abstract description 77
- 210000001778 pluripotent stem cell Anatomy 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title claims abstract description 62
- 210000000130 stem cell Anatomy 0.000 claims abstract description 81
- 238000004114 suspension culture Methods 0.000 claims abstract description 39
- 239000001509 sodium citrate Substances 0.000 claims abstract description 24
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 23
- 230000003204 osmotic effect Effects 0.000 claims abstract description 21
- 239000001103 potassium chloride Substances 0.000 claims abstract description 19
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 239000011780 sodium chloride Substances 0.000 claims abstract description 11
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims abstract description 5
- 239000002953 phosphate buffered saline Substances 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 262
- 238000000034 method Methods 0.000 claims description 110
- 239000000243 solution Substances 0.000 claims description 52
- 239000002609 medium Substances 0.000 claims description 45
- 238000004113 cell culture Methods 0.000 claims description 40
- 239000001963 growth medium Substances 0.000 claims description 23
- 230000004069 differentiation Effects 0.000 claims description 17
- 239000002738 chelating agent Substances 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 9
- 238000011143 downstream manufacturing Methods 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 7
- 230000000747 cardiac effect Effects 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000002514 epidermal stem cell Anatomy 0.000 claims description 4
- 210000001178 neural stem cell Anatomy 0.000 claims description 3
- 210000001988 somatic stem cell Anatomy 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 238000004220 aggregation Methods 0.000 claims 2
- 230000002776 aggregation Effects 0.000 claims 2
- 230000004907 flux Effects 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 175
- 238000009472 formulation Methods 0.000 description 171
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 39
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 29
- 238000010494 dissociation reaction Methods 0.000 description 26
- 230000005593 dissociations Effects 0.000 description 26
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 23
- 230000035899 viability Effects 0.000 description 20
- 210000001519 tissue Anatomy 0.000 description 18
- 230000002255 enzymatic effect Effects 0.000 description 15
- 239000011159 matrix material Substances 0.000 description 15
- 235000011164 potassium chloride Nutrition 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 13
- 239000011575 calcium Substances 0.000 description 13
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 12
- 238000010899 nucleation Methods 0.000 description 12
- 238000011534 incubation Methods 0.000 description 11
- 230000003833 cell viability Effects 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 238000007790 scraping Methods 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 9
- 239000006285 cell suspension Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 8
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 8
- 102100028096 Homeobox protein Nkx-6.2 Human genes 0.000 description 8
- 101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 description 8
- 101000578258 Homo sapiens Homeobox protein Nkx-6.2 Proteins 0.000 description 8
- 102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 description 8
- 101710144033 Pancreas/duodenum homeobox protein 1 Proteins 0.000 description 8
- 210000001900 endoderm Anatomy 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- 230000008672 reprogramming Effects 0.000 description 8
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 7
- 101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 description 6
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 description 6
- 101100310648 Mus musculus Sox17 gene Proteins 0.000 description 6
- 102100025460 Protein lin-28 homolog A Human genes 0.000 description 6
- 102100024270 Transcription factor SOX-2 Human genes 0.000 description 6
- 239000006143 cell culture medium Substances 0.000 description 6
- 238000005138 cryopreservation Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 102000000905 Cadherin Human genes 0.000 description 5
- 108050007957 Cadherin Proteins 0.000 description 5
- 102100035140 Vitronectin Human genes 0.000 description 5
- 238000013019 agitation Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 208000037068 Abnormal Karyotype Diseases 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 102000001253 Protein Kinase Human genes 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 108010007093 dispase Proteins 0.000 description 4
- 238000002224 dissection Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108060006633 protein kinase Proteins 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000001082 somatic cell Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- -1 NANOG Proteins 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108010031318 Vitronectin Proteins 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 239000002771 cell marker Substances 0.000 description 3
- 238000002659 cell therapy Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000006748 scratching Methods 0.000 description 3
- 230000002393 scratching effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000014736 Notch Human genes 0.000 description 2
- 108010070047 Notch Receptors Proteins 0.000 description 2
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003981 ectoderm Anatomy 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000001654 germ layer Anatomy 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 210000003716 mesoderm Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000013520 translational research Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 238000012604 3D cell culture Methods 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000011072 cell harvest Methods 0.000 description 1
- 230000015861 cell surface binding Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000010372 cloning stem cell Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000003890 endocrine cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000012789 harvest method Methods 0.000 description 1
- 210000003209 hepatic oval cell Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011173 large scale experimental method Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000000933 neural crest Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011536 re-plating Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 210000001912 transporting cell Anatomy 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical class [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762447262P | 2017-01-17 | 2017-01-17 | |
| US62/447,262 | 2017-01-17 | ||
| PCT/US2018/014032 WO2018136500A1 (en) | 2017-01-17 | 2018-01-17 | Passaging and harvesting formulation for single-cell human pluripotent stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110291189A true CN110291189A (zh) | 2019-09-27 |
Family
ID=61163807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201880007148.4A Pending CN110291189A (zh) | 2017-01-17 | 2018-01-17 | 单细胞人多潜能干细胞的传代和收获制剂 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190359946A1 (enExample) |
| EP (1) | EP3555264A1 (enExample) |
| JP (1) | JP7092309B2 (enExample) |
| KR (1) | KR102580997B1 (enExample) |
| CN (1) | CN110291189A (enExample) |
| CA (1) | CA3050259A1 (enExample) |
| IL (1) | IL267628B2 (enExample) |
| WO (1) | WO2018136500A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114807018A (zh) * | 2022-02-28 | 2022-07-29 | 深圳市旷逸生物科技有限公司 | 一种多能干细胞的传代方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230059873A1 (en) * | 2019-12-11 | 2023-02-23 | Repairon Gmbh | Expansion of stem cells in suspension in a bioreactor |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110097799A1 (en) * | 2009-10-19 | 2011-04-28 | Casey Stankewicz | Cardiomyocyte production |
| CA2831609A1 (en) * | 2011-03-30 | 2012-10-04 | Cellular Dynamics International, Inc. | Priming of pluripotent stem cells for neural differentiation |
| US20140212966A1 (en) * | 2011-05-17 | 2014-07-31 | Ying Nie | Passaging and harvesting formulation and method for human pluripotent stem cells |
| US20150265652A1 (en) * | 2014-03-21 | 2015-09-24 | Cellular Dynamics International, Inc. | Production of midbrain dopaminergic neurons and methods for the use thereof |
-
2018
- 2018-01-17 CN CN201880007148.4A patent/CN110291189A/zh active Pending
- 2018-01-17 JP JP2019535360A patent/JP7092309B2/ja active Active
- 2018-01-17 IL IL267628A patent/IL267628B2/en unknown
- 2018-01-17 EP EP18703413.7A patent/EP3555264A1/en active Pending
- 2018-01-17 WO PCT/US2018/014032 patent/WO2018136500A1/en not_active Ceased
- 2018-01-17 CA CA3050259A patent/CA3050259A1/en active Pending
- 2018-01-17 KR KR1020197023895A patent/KR102580997B1/ko active Active
- 2018-07-17 US US16/478,461 patent/US20190359946A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110097799A1 (en) * | 2009-10-19 | 2011-04-28 | Casey Stankewicz | Cardiomyocyte production |
| CA2831609A1 (en) * | 2011-03-30 | 2012-10-04 | Cellular Dynamics International, Inc. | Priming of pluripotent stem cells for neural differentiation |
| US20140212966A1 (en) * | 2011-05-17 | 2014-07-31 | Ying Nie | Passaging and harvesting formulation and method for human pluripotent stem cells |
| US20150265652A1 (en) * | 2014-03-21 | 2015-09-24 | Cellular Dynamics International, Inc. | Production of midbrain dopaminergic neurons and methods for the use thereof |
Non-Patent Citations (1)
| Title |
|---|
| 韩建永等: "哺乳动物PGCs用于多能性干细胞培养的研究进展", 《黑龙江畜牧兽医》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114807018A (zh) * | 2022-02-28 | 2022-07-29 | 深圳市旷逸生物科技有限公司 | 一种多能干细胞的传代方法 |
| CN114807018B (zh) * | 2022-02-28 | 2023-08-01 | 深圳市旷逸生物科技有限公司 | 一种多能干细胞的传代方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL267628B2 (en) | 2025-06-01 |
| KR20190104407A (ko) | 2019-09-09 |
| JP2020513765A (ja) | 2020-05-21 |
| IL267628B1 (en) | 2025-02-01 |
| US20190359946A1 (en) | 2019-11-28 |
| EP3555264A1 (en) | 2019-10-23 |
| IL267628A (en) | 2019-08-29 |
| WO2018136500A1 (en) | 2018-07-26 |
| CA3050259A1 (en) | 2018-07-26 |
| JP7092309B2 (ja) | 2022-06-28 |
| KR102580997B1 (ko) | 2023-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3293256B1 (en) | Automated method and apparatus for embryonic stem cell culture | |
| US7947499B2 (en) | Method of dynamically culturing embryonic stem cells | |
| KR102151588B1 (ko) | hUTC 성장을 위한 영양 강화 배지 | |
| Cuesta-Gomez et al. | Suspension culture improves iPSC expansion and pluripotency phenotype | |
| US10487312B2 (en) | Passaging and harvesting formulation and method for human pluripotent stem cells | |
| MX2011005288A (es) | Celulas madre pluripotentes en microportadores. | |
| JP2022535192A (ja) | 多能性細胞凝集体およびそれらの使用 | |
| Inamdar et al. | Derivation and characterization of two sibling human embryonic stem cell lines from discarded grade III embryos | |
| CN110291189A (zh) | 单细胞人多潜能干细胞的传代和收获制剂 | |
| Chen et al. | Expansion of human embryonic stem cells on cellulose microcarriers | |
| JP2022504764A (ja) | 細胞培養のための組成物および方法 | |
| CN101443445A (zh) | 用于增殖人胚泡衍生干细胞的培养系统和方法 | |
| WO2015008275A1 (en) | Methods for large scale generation of stem cells | |
| CN115029302B (zh) | 一种维持小鼠胚胎干细胞干性的培养方法 | |
| CN119752778A (zh) | 一种促进胚胎干细胞多能性向全能性转化的化学小分子组合应用方法 | |
| Fok | Development of a scalable bioprocess for the culture of undifferentiated murine embryonic stem cells | |
| Brena | Characterization of Human Embryonic Stem Cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |